We wanted to describe the MR imaging findings of endometrial cancer in patients with a history of prior radiation therapy for cervical cancer (ECRT) and we compare them to the MR imaging findings of patients with spontaneously occurring endometrial cancer (SEC). Materials and Methods: Twenty-two patients with endometrial cancer that was diagnosed by operation or endometrial biopsy were included in the study. The patients were divided into two groups according to the presence of past RT for cervical cancer: ECRT (n = 4) and SEC (n = 18). The MR images were retrospectively analyzed by consensus of two experienced radiologists. The MR imaging findings were analyzed by the size, shape and signal intensity of the mass, distension of the uterine cavity, the presence of cervical stenosis and the nature of the fluid collection. Results: For the mass shape, all the ECRT lesions were polypoid masses. However, the SEC patients had 5 polypoid masses and 13 wall thickenings. The maximal diameter, signal intensity and enhancement pattern of the masses were not different between the ECRT and SEC patients. The width of the endometrial cavity varied between 3.9 cm in the ECRT patients and 0.4 cm in the SEC patients (p =0.002). All the ECRT patients had cervical stenosis. However, none of the SEC patients had cervical stenosis. Conclusion: MR imaging of ECRT patients demonstrated prominent distension of their uterine cavity and cervical stenosis, which may be the result of radiation fibrosis in the uterus.
Endometrial cancer is the seventh most common malignant disorder worldwide, but its incidence varies between different geographic regions (1) . Clinically, patients who have endometrial cancer generally present with abnormal uterine bleeding. The findings, when performing endocervical curettage and suction endometrial biopsy, confirm the diagnosis of endometrial cancer and provide the tumor grade and histologic type (2, 3) . MR imaging has only a small role in detecting endometrial cancer. However, MR imaging is considered the most accurate imaging technique for the preoperative assessment of endometrial cancer due to its excellent soft-tissue contrast (4 7).
Radiation therapy (RT) is the standard treatment for most patients with stages IIB-IVA cervical cancer (8) .
The patients who have survived after RT for cervical cancer have frequently developed secondary malignancies such as uterine sarcoma, bladder cancer, vaginal cancer and cancer of the overlying integument because RT treatment is relatively successful and many patients survive long enough to be at risk for the late complications from radiotherapy. The incidence of endometrial cancer, as a second malignancy following radiation, is very low. The endometrial carcinomas arising after RT for treating cervical cancers are poorly differentiated and they are usually diagnosed at an advanced stage (9 11) . We hypothesized that the MR imaging findings of endometrial cancer in patients with a history of prior radiation therapy for cervical cancer (ECRT) can be differentiated from the MR imaging findings of spontaneously occurring endometrial cancer (SEC). SEC patients usually undergo MRI and they have a known histological diagnosis via endometrial biopsy. In contrast, ECRT patients, because of their cervical stenosis, cannot undergo endometrial biopsy and they are being imaged when cancer is suspected. Thus, for ECRT patients, the radiologist must make the initial diagnosis of cancer. The purpose of this study was to describe the MR imaging findings of ECRT patients and we compared these findings with the MR findings of SEC patients.
Materials and Methods
The records in the radiology-pathology databases from October 2002 to September 2004 at two institutions included four ECRT patients. From October 2002 to September 2004, 18 consecutive patients with SEC without RT were retrospectively evaluated at one institution. All the patients were referred to the radiology department for MR imaging. Their mean age was 55.4 12.8 years. All the patients had their diagnosis confirmed by endometrial biopsy (n=3) or operation (n=19). The patients were divided into two groups according to the past performance of RT. The mean age of the ECRT patients was 53.5 4.2 and the mean age of the SEC patients was 55.8 14.0. The mean latency period of the ECRT was 10.3 years. The stage was determined by retrospectively applying the FIGO staging criteria via the operative and pathologic findings at surgery for the ECRT patients and via the imaging and biopsy pathologic findings in the other SEC patients (12) .
All the patients underwent MR imaging with a 1.5T MR scanner (GE Signa Horizon; GE Healthcare, Milwaukee, WI, U.S.A.) and with using a body coil. The T1-weighted spine-echo images with a repetition time of 500 ms and an echo time of 8 ms were obtained in the axial plane. The T2-weighted spine-echo images with a repetition time of 3,500 3,800 ms and an echo time of 80 90 ms were obtained in the axial and sagittal planes. The Imaging parameters were a 5 mm section thickness, a 1 mm intersection gap and a 512 224 matrix. The contrast-enhanced, fat-suppressed, gradient echo T1-weighted images (TR/TE = 120/1.7 ms, Flip angle = 90 , 5 mm section thickness) were obtained after the administration of 0.1 mmol gadolinium per kilogram of body weight. The shape of the mass, the maximal diameter of the mass, the signal intensity of the mass and the enhancement pattern of the mass, the width of the endometrial cavity and the signal intensity of the fluid on the MR images were all analyzed by two experienced radiologists working in consensus. The shape of mass was classified as an irregular polypoid mass and/or wall thickening. When a mass was pedunculated, which resulted in an acute angle between the mass and the uterine wall, then the shape of the mass was considered as a polypoid mass. The maximal diameter of the mass was classified according to the thickest diameter of the thick walled lesion and the maximal size of the polypoid mass. The signal intensity of the mass was classified into hyperintense, hypointense or isointense, relative to the signal intensity of the myometrium.
The size of the mass and the width of the uterine body between the ECRTs and SECs were analyzed with using the Mann-Whitney U test.
Results
The distribution of the tumor stages for the ECRT was stage I: 1, stage II: 1, stage III: 2 and stage IV: 1. All the SEC patients were stage I. The histologic types of ECRT were as follows; subtypes of papillary serous carcinoma: 2, clear cell carcinoma: 1 and endometroid carcinoma: 1. In contrast, all the SEC patients had endometroid carcinoma.
Regarding the mass shape, all lesions of the ECRT patients were polypoid masses (Fig. 1) . However, the SEC lesions showed five polypoid masses and 13 wall thickenings (Fig. 2) . The maximal diameter of the masses varied between 1 cm and 2.6 cm (mean SD: 1.53 0.75 cm) for the ECRT patients and between 0.5 cm and 3.5 cm (mean SD: 2.25 1.07 cm) for the SEC patients (p = 0.157).
For the SEC patients, all the lesions of the 22 patients demonstrated iso-signal intensity lesion on the T1-493 A B Fig. 1 . A 48-year-old woman with endometrial cancer 14 years after radiation therapy. A. The axial T1-weighted MR image shows multiple, polypoid isointense masses (arrows) within the distended endometrial cavity. The signal intensity of the fluid within the endometrial cavity is hyperintense, which is suggestive of hematoma. B. The sagittal T2-weighted MR image reveals polypoid, hyperintense masses (arrows) in the markedly distended endometrial cavity. Fig. 2 . A 48-year-old woman with spontaneous endometrial cancer. A. The sagittal T2-weighted image shows the hyperintense thickened lesion of the endometrium (arrows). B. The contrast-enhanced gradient echo sagittal T1-weighted image demonstrates the homogenous enhancing endometrial cancer (arrows) with an intact junction zone.
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weighted images and high signal intensity lesion on the T2-weighted images. For the ECRT patients, three of four patients (75%) showed heterogeneous enhancement and one patient showed homogeneous enhancement on the contrast enhanced T1-weighted images. However, for the SEC patients, 13 of 18 patients (72.2%) showed heterogeneous enhancement.
The width of the endometrial cavity varied between 1.6 cm and 5.2 cm (mean SD: 3.9 1.7 cm) in the ECRT patients, whereas for the SEC patients, the width of the endometrial cavity varied between 0.1 cm and 2.7 cm (mean SD: 0.6 0.7 cm). The width of the endometrial cavity in the ECRT patients was wider than that of the SEC patients (p=0.002) (Fig. 1) . In all patients, the signal intensity of the fluid in the endometrial cavity appeared cystic as hypointensity on the T1-weighed images and as hyperintensity on the T2-weighted images, except for 2 ECRT patients. These 2 patients had hematoma in the endometrial cavity.
All ECRT patients had cervical stenosis and this was established via pelvic exams. However, there was no cervical stenosis in all the SEC patients.
Discussion
Endometrial tissue can persist after administering RT for cervical carcinoma, and so the risk of developing endometrial carcinoma must be considered. ECRT may develop from the remnant endometrial tissue; however, theses cases are very rare. Most ECRT patients are asymptomatic, but the advanced cases complain of lower abdominal distension or pain. The MRI findings of ECRT are a polypoid mass with prominent distension of the endometrial cavity or a distended endometrial cavity with a large tumor filling it. The prognosis of ECRT is poorer than that for SEC.
Several studies have reported that aggressive adenocarcinomas developed after administering RT for cervical carcinoma, implicating radiation as a carcinogenic factor for the development of this aggressive histological subtype (10, 13) . In our study, 75% of the patients (3/4) had aggressive subtypes of adenocarcinoma such as papillary serous carcinoma or clear cell carcinoma. Papillary serous carcinoma and clear cell carcinoma are significantly more common in black women. Patients with papillary serous carcinoma and clear cell carcinoma are more likely to have pelvic and periaortic tumor involvement (14) .
The significance of ionizing radiation as a risk factor for the development of endometrial cancer is currently unresolved. However, given the age of diagnosis, the latent period and the preponderance of high-risk histologic types, radiation is likely to be the cause. Therefore, it is important to continue careful annular surveillance even if the patient has been free of disease for many years, as the mean latency period for developing endometrial cancer is 10 14 years (9, 13). In our study, endometrial cancers were diagnosed at a mean of 10.3 years after administering radiation for cervical cancer, supporting that this should be sufficient time to exclude the presence of this tumor at the time of irradiation (9 11). Radiation-induced cervical stenosis may prevent the patient from displaying early symptoms and this complicates efforts to obtain a tissue sample for diagnosis. Unlike the SEC patients, whose first symptoms are typically vaginal bleeding, the patients with ECRT usually presented with the signs and symptoms of an enlarge uterus and pelvic pain, indicating relatively advanced disease (13) . In our study, three ECRT patients (75%) had their disease detected at advanced stages (stages II-IV), whereas all the cases of SEC were stage I.
The MR images of endometrial carcinoma have shown various abnormal endometrial findings. The endometrium may be thickened focally or diffusely, and this seen as being irregular in thickness and configuration, or as widened via polypoid tumor (5, 7). Polypoid masses were revealed in all ECRT patients (100%), whereas polypoid masses were seen in five SEC patients (27.8%) in our study. It seems to us that a polypoid mass was seen only in the ECRT patients who have hydrometra. On the other hand, the endometrial thickening was more commonly seen in SEC patients whose cavities were collapsed.
The signal intensity of the tumor shows various patterns on the T1-weighted and T2-weighted images (7). In our study, although the signal intensity and enhancement pattern on the MR imaging were not different between the ECRT and SEC patients, prominent widening of the endometrial cavity was revealed in the ECRT patients compared with the SEC patients. The cause of this may be radiation fibrosis with cervical stenosis.
The limitation of this study is the small number of ECRT patients. Because the development of ECRT is quite rare, only 4 patients belonging to this group were included in this study. A future study is needed to describe the MR imaging in a large number of ECRT patients.
In summary, it is important to recognize that ECRT patients may show a high-risk histological subtype and a history of pelvic radiation for treating cervical cancer. The MR imaging findings of ECRT patients showed a polypoid mass with prominent distension of the endometrial cavity, as compared with SEC patients.
